WilmerHale Successfully Represents Mayne in its Acquisition by Hospira

WilmerHale Successfully Represents Mayne in its Acquisition by Hospira

Client News

Related Solutions

We offer clients exceptional insight in dealing with competition agencies in the United States, Europe and around the world.
Antitrust and Competition

WilmerHale successfully represented its client Mayne Pharma Ltd. before the US Federal Trade Commission to secure antitrust clearance of Mayne's acquisition by Hospira, Inc. The transaction will make Hospira one of the world's leading generic injectable drug manufacturers. The January 18, 2007 clearance decision required no divestitures material to the transaction and came only two and a half months after the Commission initiated a Second Request investigation.

The WilmerHale antitrust lawyers working on the transaction included William Kolasky, Jeff Ayer, Andrew Ewalt, Laura Hill, Alexander Krulic, Elizabeth de Luca, Jeffrey Schomig, Deirdre Waters, and Dan Matheson.

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.

I Accept Cancel